Sentences with phrase «study by cancer treatment»

Pembrolizumab, or pembro, an immunotherapy drug that unmasks cancer cells and allows the body's own immune system to help destroy tumors, appears to be safe in treating lung cancers, according to a study by Cancer Treatment Centers of America ® (CTCA) at Western Regional Medical Center (Western) in Goodyear, Arizona.

Not exact matches

Chicago, GenomeWeb — A new study by researchers from Memorial Sloan Kettering Cancer Center has demonstrated the predictive power of an AR - V7 protein expression test using Epic Sciences» non-EPCAM-based circulating tumor cell detection platform, which could help guide treatment decisions for men with metastatic castration - resistant prostate cCancer Center has demonstrated the predictive power of an AR - V7 protein expression test using Epic Sciences» non-EPCAM-based circulating tumor cell detection platform, which could help guide treatment decisions for men with metastatic castration - resistant prostate cancercancer.

Cancer treatment guidelines produced by the US National Comprehensive Cancer Network (NCCN) are often based on low quality evidence or no evidence at all, finds a study published by The BMJ today.

A one - two combo punch using two currently available drugs could be an effective treatment for the majority of lung cancers, a study by scientists with UT Southwestern's Simmons Cancer Center shows.

Called the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS) and funded by the drug giant Novartis, the trial also found fewer cases of lung cancer in those on the treatment, rekindling basic research findings hinting that the same inflammatory pathway may initiate or spur the growth of such tumors.

A study led by The University of Texas MD Anderson Cancer Center has opened up yet another avenue for understanding the biological reasons why some people live longer or respond better to treatment — RNA editing events.

GIS's DNA analysistechnique has allowed the researchers to further study the biology of Opisthorchis viverrini to understand the cause and the eventual development of treatments for bile duct cancer, a condition caused by the parasite.

In the study published in the journal Science Signaling, the team led by LLuís Espinosa, investigator of IMIM's research group into stem cells and cancer, have shown that inhibition of endosomal activity is a potential therapeutic strategy for the treatment of cancers with the BRAF mutated gene.

The new doubts over psoralen stem partly from a study funded by the Brussels - based European Organization for Research and Treatment of Cancer.

«By understanding how stress accelerates invasion in aggressive breast tumor cells, this work will inform future studies into whether beta - blockers could be a useful adjuvant therapy in the treatment of some aggressive breast cancers.»

«Other studies have looked at racial disparities in treatment and still others have focused on racial differences in survival rates of cancer patients, but our research attempted to go further by demonstrating the impact of race - based inequalities in cancer treatment on survival rates of black colorectal cancer patients,» said James D. Murphy, MD, MS, assistant professor and chief of the Radiation Oncology Gastrointestinal Tumor Service at UC San Diego Moores Cancer Ccancer patients, but our research attempted to go further by demonstrating the impact of race - based inequalities in cancer treatment on survival rates of black colorectal cancer patients,» said James D. Murphy, MD, MS, assistant professor and chief of the Radiation Oncology Gastrointestinal Tumor Service at UC San Diego Moores Cancer Ccancer treatment on survival rates of black colorectal cancer patients,» said James D. Murphy, MD, MS, assistant professor and chief of the Radiation Oncology Gastrointestinal Tumor Service at UC San Diego Moores Cancer Ccancer patients,» said James D. Murphy, MD, MS, assistant professor and chief of the Radiation Oncology Gastrointestinal Tumor Service at UC San Diego Moores Cancer CCancer Center.

Dr. Tordjman and her colleagues studied the effect of radioactive iodine treatment on the ovarian reserve of women treated for differentiated thyroid cancer (DTC) by measuring their blood levels of anti-Müllerian hormone (AMH) and following the patients for up to one year after treatment.

«Since 95 percent of cancer patients still get chemo, we realized we could make a major impact on cancer treatment by helping clinicians prescribe the right chemotherapy drug,» said Sourav Bandyopadhyay, PhD, a professor of bioengineering and therapeutic sciences in UCSF's Schools of Pharmacy and Medicine and senior author on the new study.

The first long - term study of a pioneering endoscopic laser treatment for early vocal - cord cancer, developed at Massachusetts General Hospital (MGH) and previously shown to provide optimal voice outcomes, finds that it is as successful as traditional approaches in curing patients» tumors while avoiding the damage to vocal quality caused by radiotherapy or by conventional laser or cold - instrument surgery.

A new study led by University of Kentucky researchers suggests a new approach to develop highly - potent drugs which could overcome current shortcomings of low drug efficacy and multi-drug resistance in the treatment of cancer as well as viral and bacterial infections.

Researchers at Oregon State University are pursuing a new concept in treatment of epithelial cancer, especially head and neck cancer, by using two promising «analogs» of an old compound that was once studied as a potent anti-tumor agent, but long ago abandoned because it was too toxic.

«Children conceived after fertility treatments are at increased risk for pediatric cancers: Study conducted by Ben - Gurion University and Soroka University Medical Center.»

A study by the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) has found new interactions between two molecules involved in acute myeloid leukemia (AML), STAT3 and PRL - 3, which may offer a new therapeutic target for cancer treaCancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) has found new interactions between two molecules involved in acute myeloid leukemia (AML), STAT3 and PRL - 3, which may offer a new therapeutic target for cancer treacancer treatment.

In the analysis of 23 relevant studies, investigators found that many clinicians are broadly informed about the risk to their patients» fertility brought about by cancer treatment, but many factors hinder the appropriate discussions and referrals needed to provide adequate fertility support to patients of reproductive age.

An international study led by scientists from the Crick Institute in London and the Hebrew University of Jerusalem revealed a survival mechanism in cancer cells that allows the disease to erupt again even after aggressive treatment.

Studies show that the efficacy of some vaccines and cancer treatments may be affected by the time of day when a therapy is administered or medicine is taken.

A Yale Cancer Center study may have solved this mystery by identifying how cancer cells escape treatment, leading to recurCancer Center study may have solved this mystery by identifying how cancer cells escape treatment, leading to recurcancer cells escape treatment, leading to recurrence.

Despite findings of previous studies and published guidelines, nearly two - thirds of patients with T4a larynx («voice box») cancer are not receiving a total laryngectomy (surgical removal of the larynx), the recommended form of treatment, and as a result, have significantly worse survival rates versus those treated with a total laryngectomy, a new study published in the International Journal of Radiation Oncology, Biology and Physics by experts at Penn Medicine found.

However, Professor Anderson stressed that the results of the study related only to subsequent pregnancy itself, and not to the incidence of infertility caused by cancer treatment.

The study, published in the journal Science Translational Medicine, is an important step towards use of «liquid biopsies» to revolutionise breast cancer care — by changing the way cancer is monitored in the clinic and informing treatment decisions.

By identifying novel biological pathways and publishing details of these interactions, the study team aims to help uncover useful targets in developing better vaccines and cancer treatments.

In a recent study, published in Kidney International, researchers from Duke - NUS Medical School (Duke - NUS) in Singapore and Duke University have shown that drugs that target Wnt secretion by inhibiting Porcupine, a protein usually targeted for cancer treatment, may reduce renal fibrosis and protect the kidneys.

Through the study, researchers were also able to pinpoint three different brain changes caused by the progression of cancer and the drugs used in treatment.

The memory and thinking problems experienced by cancer survivors, known as «chemo brain» or «chemo fog,» are not just the result of chemotherapy treatment, they may start as tumors form and develop, suggests a Baycrest - led study.

By matching normal and cancer cells from a patient, we can now study the differences — what molecules are key to tumor development and growth, and, ultimately, match treatments that might disable this cancer,» says the study's senior investigator, associate professor of pathology, Xuefeng Liu, MD, a member of the Center for Cell Reprogramming (CCR) at Georgetown University Medical Center.

A study led by scientists at The Wistar Institute describes a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer specific protein.

A study by researchers at Brigham and Women's Hospital (BWH) found that brachytherapy treatment was associated with better cause - specific survival and overall survival in women with cervical cancer.

A recent study by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine revealed that triple - negative breast cancer (TNBC), which has generally been unresponsive to hormone receptor - targeted treatments, can indeed be treated using vitamin D and androgen receptor - targeted thCancer Center at the University of Miami Miller School of Medicine revealed that triple - negative breast cancer (TNBC), which has generally been unresponsive to hormone receptor - targeted treatments, can indeed be treated using vitamin D and androgen receptor - targeted thcancer (TNBC), which has generally been unresponsive to hormone receptor - targeted treatments, can indeed be treated using vitamin D and androgen receptor - targeted therapy.

The New EPOC study, published in The Lancet Oncology and funded by Cancer Research UK, evaluated whether the drug cetuximab and chemotherapy together worked better than chemotherapy alone as a treatment in addition to surgery for people with bowel cancer that had spread to the liver but could be surgically reCancer Research UK, evaluated whether the drug cetuximab and chemotherapy together worked better than chemotherapy alone as a treatment in addition to surgery for people with bowel cancer that had spread to the liver but could be surgically recancer that had spread to the liver but could be surgically removed.

Published by Noha Sharafeldin, M.D., M.Sc., Ph.D., instructor in UAB's Institute for Cancer Outcomes and Survivorship and Division of Hematology and Oncology, this study helps add a missing piece to a long - unsolved puzzle about post-transplant effects on recipients, specifically that vulnerable subpopulations of similar transplants can benefit from targeted interventions in the years after they receive their lifesaving treatment.

A study led by UCLA's Drs. Robert Prins and Linda Liau, both UCLA Jonsson Comprehensive Cancer Center members, looked at the impact of a combined treatment using a chemotherapy drug called decitabine and genetically modified immune cells or T cell immunotherapy.

A new study led by scientists at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James) suggests that dopamine — an inexpensive drug currently used to treat heart, vascular and kidney disorders — can be safely used in cancer treatment to curb the growth of blood vessels in tCancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James) suggests that dopamine — an inexpensive drug currently used to treat heart, vascular and kidney disorders — can be safely used in cancer treatment to curb the growth of blood vessels in tCancer Hospital and Richard J. Solove Research Institute (OSUCCC — James) suggests that dopamine — an inexpensive drug currently used to treat heart, vascular and kidney disorders — can be safely used in cancer treatment to curb the growth of blood vessels in tcancer treatment to curb the growth of blood vessels in tumors.

Pembrolizumab, an antibody drug already used to treat other forms of cancer, can be effective in the treatment of the most common form of mesothelioma, according to a new study led by investigators from the Perelman School of Medicine at the University of Pennsylvania.

To determine whether the reactivation of methylation - silenced genes by EGCG is a general phenomenon that also occurs in other cell lines, we studied the effects of EGCG treatment on the methylation status and mRNA levels of p16INK4a or RARβ in three other human cancer cell lines (Fig. 3C) ⇓.

The study results were published online June 1 by the journal Breast Cancer Research and Treatment, and were presented June 4 at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago.

As the researchers put it: «Our study demonstrates that the disparity in testing is not explained by differences in the doctors that black and white women see for their cancer treatment.

The study on racial disparities in prostate cancer treatment was conducted by the University of North Carolina Lineberger.

The scientists recently received a five - year, $ 1.6 million grant from the National Institute of Dental & Craniofacial Research, a part of the National Institutes of Health, to study stem cells that may restore salivary gland tissue damaged by cancer treatment.

Overweight pediatric cancer patients who eat a healthy diet and exercise regularly may improve outcomes and reduce treatment side effects that cause disease, according to a review study led by researchers at MD Anderson Children's Cancer Hoscancer patients who eat a healthy diet and exercise regularly may improve outcomes and reduce treatment side effects that cause disease, according to a review study led by researchers at MD Anderson Children's Cancer HosCancer Hospital.

Moreover, PHENONIM - ICS is involved in European projects presenting a strong impact on human health: Interreg CARDIOGENE (Genetic mechanisms of cardiovascular diseases), GENCODYS (Genetic and epigenetic networks involved in cognitive dysfunctions), AgedBrainSYSBIO (Basic studies of brain aging), as well as projects in partnership with industry: MAGenTA (an Industrial Strategic Innovation project supported by Bpifrance about the treatment of major urogenital diseases) and CanPathPro (H2020 program), to develop a predictive modeling platform of signaling pathways involved in cancers.

He is currently funded (2016 - 2021) by the National Cancer Institute to study radiation induced changes in neuron cell dendritic morphology in cancer treatment with X-rays, protons and carbon beams, and has received grants from the Department of Energy and NASA in theCancer Institute to study radiation induced changes in neuron cell dendritic morphology in cancer treatment with X-rays, protons and carbon beams, and has received grants from the Department of Energy and NASA in thecancer treatment with X-rays, protons and carbon beams, and has received grants from the Department of Energy and NASA in the past.

Permanent discontinuation of study medication was required by protocol for women who developed breast cancer, endometrial pathologic state (hyperplasia not responsive to treatment, atypia, or cancer), deep vein thrombosis (DVT) or PE, malignant melanoma, meningioma, triglyceride level greater than 1000 mg / dL (11.3 mmol / L), or prescription of estrogen, testosterone, or selective estrogen - receptor modulators by their personal physician.

Other studies by CRI scientists that are shedding light on the understanding and treatment of colorectal cancer include:

«A number of these assays and associated bioinformatics software have been validated for use in Invivoscribe's own «LabPMM» clinical laboratories, and they are currently being used by leading cancer treatment centers and pharmaceutical partners, both to optimize treatments for patients, and to stratify, enroll, and track residual disease in patients in international phase II and phase III clinical studies.

Because Akt is an important factor in the differentiation and immune function of T cells, and previous studies showed that VPA and other HDAC inhibitors could inhibit Akt activity in cancer cells (41, 42), we examined whether Akt activity was modulated by VPA treatment.